Effects of COVID-19 on the liver: The experience of a single center

Table 2 Coronavirus disease 2019 pneumonia severity indices of patients with elevated liver enzymes (group 1) versus normal liver enzymes (group 2)

	Group 1 (n = 603)		Group 2 (n = 81)		P value
		Number of tested		Number of tested
Moderate COVID, n/%	436/72.2	603	64/79.0	81	0.4341
Severe COVID, n/%	134/22.4		14/17.3
Critical COVID, n/%	33/5.4		3/3.7
O2 demand, n/%	188/31.2	603	21/25.9	81	0.3354
SpO2, %, range	94.4 ± 3.5, 68-100	594	95.3 ± 2.9, 84-99	76	0.0169
Respiratory rate, n/min, range	18.4 ± 3.2, 14-40	543	17.7 ± 2.4, 14-28	72	0.0291
Mortality, total, n/%	17/2.8	603	3/3.7	81	0.6573
CRP, mg/L, range	72.3 ± 68.9, 0.4-459.0	571	54.2 ± 56.1, 0.6-327.0	70	0.0151
IL-6, ng/L, range	50.3 ± 120.0, 3-2499	546	35.7 ± 38.9, 2-188	65	0.0402
LDH, U/L, range	357.9 ± 134.0, 167-979	435	299.0 ± 173.4, 134-1304	49	0.0254

COVID: Coronavirus disease; CRP: C-reactive protein; LDH: Lactate dehydrogenase; IL-6: Interleukine-6.